LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Thursday, February 7, 2008 at 1:00 pm (ET) at the Grand Hyatt Hotel in New York.
